Clinical trialNCT00613002CompletedPhase 3Interventional

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

SponsorBioSante PharmaceuticalsEnrollment597Hypoactive Sexual Desire Disorder

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a randomized, double-blind, placebo-controlled, multi-center study of the safety and efficacy of LibiGel® 300mcg in the treatment of HSDD in surgically menopausal women

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael C Snabes, MD, PhD
BioSante Pharmaceuticals, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

63 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Biosante Site #188
Sarnia, Ontario, Canada
Biosante Site #054
Windsor, Ontario, Canada
Biosante Site #193
Shawinigan, Quebec, Canada

United States

Biosante Site #215
Birmingham, Alabama, United States
Biosante Site #095
Hoover, Alabama, United States
Biosante Site #014
Huntsville, Alabama, United States
Biosante Site #027
Glendale, Arizona, United States
Biosante Site #040
Tucson, Arizona, United States
Biosante Site #052
Hot Springs, Arkansas, United States
Biosante Site #182
Buena Park, California, United States
Biosante Site #008
San Diego, California, United States
Biosante Site #007
Denver, Colorado, United States
Biosante Site #216
Denver, Colorado, United States
Biosante Site #036
Ridgefield, Connecticut, United States
Biosante Site #013
Washington D.C., District of Columbia, United States
Biosante Site #024
Miami, Florida, United States
Biosante Site #219
Pinellas Park, Florida, United States
Biosante Site #041
St. Petersburg, Florida, United States
Biosante Site #009
West Palm Beach, Florida, United States
Biosante Site #189
Addison, Illinois, United States
Biosante Site #005
Shreveport, Louisiana, United States
Biosante Site #004
Baltimore, Maryland, United States
Biosante Site #044
Detroit, Michigan, United States
Biosante Site #047
Grand Rapids, Michigan, United States
Biosante Site #033
Saginaw, Michigan, United States
Biosante Site #031
Saint Clair Shores, Michigan, United States
Biosante Site #208
Edina, Minnesota, United States
Biosante Site #198
Saint Paul, Minnesota, United States
Biosante Site #051
Missoula, Montana, United States
Biosante Site #006
Lincoln, Nebraska, United States
Biosante Site #217
Las Vegas, Nevada, United States
Biosante Site #015
Poughkeepsie, New York, United States
Biosante Site #059
Cary, North Carolina, United States
Biosante Site #079
Charlotte, North Carolina, United States
Biosante Site #061
Winston-Salem, North Carolina, United States
Biosante Site #056
Fargo, North Dakota, United States
Biosante Site #210
Akron, Ohio, United States
Biosante Site #212
Cincinnati, Ohio, United States
Biosante Site #213
Columbus, Ohio, United States
Biosante Site #050
Eugene, Oregon, United States

23 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo gelTestosterone gel

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2006
Primary completion: 30 Sept 2011
Completion: 30 Sept 2011
Last update posted: 10 Jan 2013
Registered enrollment: 597
Registry id: NCT00613002

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.